No amount of expensive advertising alters the fact that Restasis is not a very effective treatment for Dry Eye Syndrome.  The drug has not been approved by authorities in the European Union, Australia or New Zealand.  Use in Canada is tightly controlled and strictly limited.  Studies suggest only minimal improvement compared to the significant cost.